![Todd Wider](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Todd Wider
Director/Board Member at
ASP ISOTOPES INC.
Net worth: 3 M $ as of 2026-07-30
Profile
Todd Wider is currently Director at Varian Biopharmaceuticals, Inc., Director at Varian Biopharma, Inc., Independent Non-Executive Director at ASP Isotopes, Inc. since 2021, Independent Director at Genenta Science SpA since 2024, and Principal at Wider Film Projects.
Former roles include Executive Chairman & Chief Medical Officer at Emendo Biotherapeutics, Inc. from 2018 to 2024, Independent Director at Abeona Therapeutics, Inc., Independent Director at ARYA Sciences Acquisition Corp.
from 2018 to 2020, Independent Director at ARYA Sciences Acquisition Corp.
II in 2020, Independent Director at ARYA Sciences Acquisition Corp.
IV, Independent Director at ARYA Sciences Acquisition Corp.
V, Independent Director at ARYA Sciences Acquisition Corp.
III from 2020 to 2021, Director at Lyfebulb LLC, and Principal at Memorial Sloan Kettering Cancer Center.
Education includes undergraduate studies at Princeton University and a doctorate from Columbia University College of Physicians & Surgeons.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ASP ISOTOPES, INC. 0.53% | 2026-06-29 | 672,247 ( 0.53% ) | 3 M $ | 2026-07-30 |
Todd Wider active positions
| Companies | Position | Start |
|---|---|---|
| ASP ISOTOPES INC. | Director/Board Member | 2021-09-30 |
| GENENTA SCIENCE S.P.A. | Director/Board Member | 2024-05-01 |
Wider Film Projects | Corporate Officer/Principal | - |
Varian Biopharmaceuticals, Inc.
 Varian Biopharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel therapeutics for the treatment of cancer | Director/Board Member | - |
Former positions of Todd Wider
| Companies | Position | End |
|---|---|---|
Emendo Biotherapeutics, Inc.
 Emendo Biotherapeutics, Inc. BiotechnologyHealth Technology Operates genome editing company that develops genetic medicines and cell therapies for severe diseases | Chairman | 2024-02-29 |
| ARYA SCIENCES ACQUISITION III A | Director/Board Member | 2021-05-31 |
| CEREVEL THERAPEUTICS HOLDINGS, INC. | Director/Board Member | 2020-10-31 |
| ARYA SCIENCES ACQUISITION CORP. | Director/Board Member | 2020-02-29 |
Memorial Sloan Kettering Cancer Center
 Memorial Sloan Kettering Cancer Center Hospital/Nursing ManagementHealth Services Operates as a nonprofit cancer hospital | Corporate Officer/Principal | - |
Training of Todd Wider
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
45
1st degree connections
15
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 15 |
|---|---|
Abeona Therapeutics, Inc.
 Abeona Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes cell and gene therapies for life-threatening rare genetic diseases | Health Technology |
Princeton University
 Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center Hospital/Nursing ManagementHealth Services Operates as a nonprofit cancer hospital | Health Services |
Columbia University College of Physicians & Surgeons
 Columbia University College of Physicians & Surgeons Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Genenta Science SpA
 Genenta Science SpA Pharmaceuticals: MajorHealth Technology Develops gene transfer therapy for the treatment of cancer tumors | Health Technology |
ARYA Sciences Acquisition Corp.
 ARYA Sciences Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Emendo Biotherapeutics, Inc.
Emendo Biotherapeutics, Inc. BiotechnologyHealth Technology Operates genome editing company that develops genetic medicines and cell therapies for severe diseases | Health Technology |
ARYA Sciences Acquisition Corp. II
 ARYA Sciences Acquisition Corp. II Financial ConglomeratesFinance Operates as a blank check company | Finance |
Lyfebulb LLC
 Lyfebulb LLC Internet Software/ServicesTechnology Services Operates as an online digital platform for people living with chronic illnesses | Technology Services |
Wider Film Projects | |
ARYA Sciences Acquisition Corp. III
 ARYA Sciences Acquisition Corp. III Financial ConglomeratesFinance Operates as a blank check company | Finance |
ARYA Sciences Acquisition Corp. IV
 ARYA Sciences Acquisition Corp. IV Financial ConglomeratesFinance Operates as a blank check company | Finance |
Varian Biopharmaceuticals, Inc.
Varian Biopharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel therapeutics for the treatment of cancer | Health Technology |
ARYA Sciences Acquisition Corp. V
 ARYA Sciences Acquisition Corp. V Financial ConglomeratesFinance Operates as a blank check company | Finance |
ASP Isotopes, Inc.
 ASP Isotopes, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pre-commercial stage materials company that produces, distributes, markets and sells isotopes | Health Technology |
- Stock Market
- Insiders
- Todd Wider
